ECP Patient Guidelines

External Counterpulsation Therapy (ECP Therapy) has documented great benefit for many cardiac patients in several credible, peer reviewed journals such as the New England Journal of Medicine and the Journal American College of Cardiology. However, in order to be eligible for reimbursement from Medicare & private insurance, you must adhere to the standard guidelines put forth by the Centers for Medicare & Medicaid.

Candidates for ECP Therapy must fit the following Criteria:

  • Documented minimal Coronary Artery Disease (Objective Assessment “B” means evidence of minimum cardiovascular disease) by way of Angiography, Stress test, Nuclear scan, Cardiac Ultrasound, EKG, Holter etc.
  • Symptoms with Physical Exertion – Patients that are comfortable at rest, but less than ordinary physical activity causes symptoms of:
    • Chest Pain
    • Shortness Of Breath
    • Fatigue
    • Palpitations
  • Patients are In-operable:
    • Patients with excessive risk or co-morbid condition that creates unnecessary risk for invasive procedure.
    • Patients who refuse or unwilling to take risk of another invasive procedure due to age
  • Inadequate Relief from Medication or Complications with excessive medications.
    • ECP Therapy is proven to reduce or often eliminate need for medications (Nitrates, Ranexa)

Patient Groups to Consider:

  • dreamstime_xs_10686547Post Invasive Patients are a great place to find ideal candidates for External Counterpulsation Therapy. These are patients that have had a Bipass Surgery (CABG) or Percutaneous Coronary Intervention (PCI) within the last 5 years or more. Statistics show that these patients will be symptomatic as soon as 1 year and the idea of a safe, non-invasive treatment option will be an attractive options for this group. Most cardiology practices average 400-600 active patients in this group (based on average practice size of 2500 active patients) with 75-95 of that number could qualify for ECP therapy.
  • Diabetic Patients with underlying ischemic heart disease that suffer from cardiac autonomic neuropathy often have ‘silent ischemia’ or chest pain that is often undetected due to nerve damage in the heart. These patients may experience of Shortness of Breath on physical exertion. These population could often benefit greatly from ECP therapy due to the fact that many of these patients live an inactive and unhealthily lifestyle that can benefit from the improvement in peripheral & arterial function brought from ECP therapy. Further, many of these patients are NOT good candidates for surgery as many have excessive risk and complications.
  • In-Active or Sedimentary Lifestyle patients are also great candidates for External Counterpulsation Therapy. These are the patients that avoid any activity that brings them any discomfort. Many experts say that External Counterpulsation therapy provides as much as 6 times the amount of exercise benefit per hour of treatment than any other form of tolerated physical exercise. Many of these patients are obese or elderly with many health complications that pose as a significant risk factor for other traditional invasive procedures.

Other Considerations:

  • Small vessel or diffuse disease resulting in symptomscollateral-circulation from ecp and eecp therapy
  • Incomplete revascularization or in-operable legions / vessels
  • Congestive Heart Failure patients with various symptoms with documented underlying Ischemia / CAD
  • CAD patients that live sedentary lifestyles due to CAD
  • Patients looking to restore exercise tolerance / functional capacity
  • Cardiac Syndrome X (undetectable symptoms of chest pain)
  • Patient that take excessive medication (Nitro, Ranexa) or do not get ample relief.
  • Patients looking to restore a more active quality of life.